While Wegovy (semaglutide) sales more than doubled to DKK 19.87 billion ($2.78 billion) in the three-month period, that was slightly below estimates and Novo Nordisk said is now anticipating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback